Y Inoue1, Y Tanaka2, H Hata2, T Hara3. 1. From the Departments of Diagnostic Radiology (Y.I., T.H.) inoueys34@gmail.com. 2. Radiology (Y.T., H.H.), Kitasato University Hospital, Sagamihara, Kanagawa, Japan. 3. From the Departments of Diagnostic Radiology (Y.I., T.H.).
Abstract
BACKGROUND AND PURPOSE: Arterial spin-labeling MR imaging permits safe, repeated CBF measurement. We investigated the potential and technical factors of arterial spin-labeling imaging in assessing cerebrovascular reactivity to acetazolamide. MATERIALS AND METHODS: The regional CBF was measured in 8 healthy volunteers by use of a 3D pseudocontinuous arterial spin-labeling sequence. Arterial spin labeling imaging was performed at rest and every 2 minutes after intravenous acetazolamide injection. To evaluate repeatability, regional CBF measurements were repeated without acetazolamide within an imaging session and on a separate day. Additionally, arterial spin-labeling imaging was performed at rest and after acetazolamide injection with different postlabeling delays, and regional cerebrovascular reactivity was calculated. RESULTS: The regional CBF started to increase immediately after acetazolamide injection and peaked at approximately 10 minutes, followed by a slow decrease. Favorable intrasession repeatability was demonstrated, especially when scanner tuning was omitted between scans. Rest regional CBF was slightly lower with a postlabeling delay of 2525 ms than with a postlabeling delay of 1525 ms, and the postlabeling delay-dependent difference was more evident for regional CBF after acetazolamide injection and regional cerebrovascular reactivity. CONCLUSIONS: Arterial spin-labeling imaging allows evaluation of the distribution, magnitude, and time course of cerebrovascular response to acetazolamide. The influence of the postlabeling delay on the estimated cerebrovascular reactivity should be noted.
BACKGROUND AND PURPOSE: Arterial spin-labeling MR imaging permits safe, repeated CBF measurement. We investigated the potential and technical factors of arterial spin-labeling imaging in assessing cerebrovascular reactivity to acetazolamide. MATERIALS AND METHODS: The regional CBF was measured in 8 healthy volunteers by use of a 3D pseudocontinuous arterial spin-labeling sequence. Arterial spin labeling imaging was performed at rest and every 2 minutes after intravenous acetazolamide injection. To evaluate repeatability, regional CBF measurements were repeated without acetazolamide within an imaging session and on a separate day. Additionally, arterial spin-labeling imaging was performed at rest and after acetazolamide injection with different postlabeling delays, and regional cerebrovascular reactivity was calculated. RESULTS: The regional CBF started to increase immediately after acetazolamide injection and peaked at approximately 10 minutes, followed by a slow decrease. Favorable intrasession repeatability was demonstrated, especially when scanner tuning was omitted between scans. Rest regional CBF was slightly lower with a postlabeling delay of 2525 ms than with a postlabeling delay of 1525 ms, and the postlabeling delay-dependent difference was more evident for regional CBF after acetazolamide injection and regional cerebrovascular reactivity. CONCLUSIONS: Arterial spin-labeling imaging allows evaluation of the distribution, magnitude, and time course of cerebrovascular response to acetazolamide. The influence of the postlabeling delay on the estimated cerebrovascular reactivity should be noted.
Authors: Bradley J MacIntosh; Nicola Filippini; Michael A Chappell; Mark W Woolrich; Clare E Mackay; Peter Jezzard Journal: Magn Reson Med Date: 2010-03 Impact factor: 4.668
Authors: Adolf Pfefferbaum; Sandra Chanraud; Anne-Lise Pitel; Ajit Shankaranarayanan; David C Alsop; Torsten Rohlfing; Edith V Sullivan Journal: Psychiatry Res Date: 2010-05-20 Impact factor: 3.222
Authors: Reinoud P H Bokkers; Matthias J P van Osch; H Bart van der Worp; Gert J de Borst; Willem P T M Mali; Jeroen Hendrikse Journal: Radiology Date: 2010-07 Impact factor: 11.105
Authors: Jeffrey M Pollock; Huan Tan; Robert A Kraft; Christopher T Whitlow; Jonathan H Burdette; Joseph A Maldjian Journal: Magn Reson Imaging Clin N Am Date: 2009-05 Impact factor: 2.266
Authors: Daniel F Arteaga; Megan K Strother; Carlos C Faraco; L Taylor Davis; Allison O Scott; Manus J Donahue Journal: J Magn Reson Imaging Date: 2019-04-02 Impact factor: 4.813
Authors: Emilie Sleight; Michael S Stringer; Ian Marshall; Joanna M Wardlaw; Michael J Thrippleton Journal: Front Physiol Date: 2021-02-25 Impact factor: 4.566
Authors: Inpyeong Hwang; Chul-Ho Sohn; Keun-Hwa Jung; Eung Koo Yeon; Ji Ye Lee; Roh-Eul Yoo; Koung Mi Kang; Tae Jin Yun; Seung Hong Choi; Ji-Hoon Kim Journal: Taehan Yongsang Uihakhoe Chi Date: 2021-01-29